AIMA
MGRM

Ables Iannone Moore & Associates’s Monogram Orthopaedics MGRM Stock Holding History

Ables Iannone Moore & Associates’s Portfolio MGRM Stock Details MGRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-266
Closed -$915 – 195
2023
Q4 		$915 Buy
+266
New +$802 ﹤0.01% 254

Other funds holding MGRM

FPAS
Focus Partners Advisor Solutions Saint Louis, Missouri $11.8B AUM 25.68% 1-Year Est. Return
PWM
Prosperity Wealth Management San Ramon, California $300M AUM 28.11% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ables Iannone Moore & Associates's MGRM Position: Q1 2024 in Review

Ables Iannone Moore & Associates sold out of Monogram Orthopaedics (MGRM) in Q1 2024, closing a stake of 266 shares — an estimated $915 sold.

Ables Iannone Moore & Associates first reported a position in MGRM in Q4 2023 and held it in 1 quarter. The position peaked at $915 in Q4 2023. 29 funds tracked by Wall St. Rank hold MGRM as of Q1 2024.

  • Ables Iannone Moore & Associates reported no remaining Monogram Orthopaedics position as of Q1 2024 after selling out during the quarter.
  • Ables Iannone Moore & Associates sold 266 Monogram Orthopaedics shares in Q1 2024, an estimated $915.
  • Ables Iannone Moore & Associates first reported a position in Monogram Orthopaedics in Q4 2023 and held it in 1 quarter.
  • Ables Iannone Moore & Associates's Monogram Orthopaedics position peaked at $915 in Q4 2023.
  • 29 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q1 2024.

Based on Ables Iannone Moore & Associates's 13F filing for Q1 2024, filed 30 Apr 2024.